Related Experiment Video
Updated: Aug 30, 2025
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Hybrid Nanocarriers for Neurological Disorders: Diagnostic & Therapeutic Approach
Anuradha Mishra1, Rabiya Ahsan1, Anas Islam1
1Department of Pharmacology, Faculty of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, 226026, Uttar Pradesh, India.
Background:
Around 1.5 billion people in the world are affected by complex neurological disorders, and the figure is increasing alarmingly due to unsatisfactory clinical outcomes. To date, no conventional formulation can show a promising effect on the control or prevention of neurodegeneration. However, Nano delivery tools have shown better penetration and profound action on the targeted area of the brain.
Methods:
Although existing Nano therapeutic approaches are abundant but would not reach the clinic due to their improper bioavailability, BBB restricts its entry and causes improper biodistribution, so it is a challenge to use certain bioactive as a potential therapy in neurodegenerative disorders. Hybrid nanocarriers are nano-vesicular transported systems which could be utilized as carriers for the delivery of both hydrophilic and hydrophobic compounds. Available patents on nanodelivery for therapeutic approaches will also include in this review.
Results:
Hybrid Nano delivery system may provide good stability to polar and nonpolar compounds and improve their stability.
Conclusion:
This manuscript updates the available findings on the Nano vesicular system to deliver drugs for neurodegenerative disorders.
